Giuseppe Carmassi Email & Phone Number

Milan, It

Italia

Italy-Switzerland

• Management of the Italian branch of the company and MSL for development of scientific profile of Belinostat, which is an orphan drug for Peripheral T-Cell Lymphoma, for Italy and Switzerland, in according with a job agreement between iQone and ONXEO, holder of the drug.• Follow and develop Foscavir scientific aspects, to treat CMV infection after allogeneic stem cells transplantation.• Develop scientific aspects of Tagraxofusp, and collaborate to build disease awareness on BPDCN, in according with a job agreement between iQone and Stemline Therapeutics.• Expansion of NPP program in Italy and development of a new European Phase II trial.• Support clinical trial related activities, related to patient identification, recruitment and investigator education• Develop and maintain relationships of key opinion leaders and principal investigators• Identify key national and regional thoughts leaders and any other external expert of interest for Belinostat, Foscavir and Tagraxofusp• Coordinate medical education to external stakeholders • Identify coordinate, evaluate and monitor investigator-sponsored trials intended to support the clinical and scientific strategy of Belinostat, Foscavir and Tagraxofusp.• Assist in development of, and participate in, regional advisory board and medical education programs• Coordinate activities through AIFA and iQone Healthcare.

Italy

Organization of Italian start up under all aspects.Launched and Development of company business: Zevalin, radioimmunotherapy for treatment of NHL.Responsible for the Italian Scientific Service of Sepctrum Pharmaceuticals BVResponsible for sales implementation in ItalyConnection between Spectrum Pharmaceutical BV and Italian Committe

Milan Area, Italy

Laurea, Farmacia

Laurea In Farmacia